Savvas N. Savvides

Gent, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications

Author Correction: Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.

Author Correction: Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.

Journal: Nature medicine
Published: September 02, 2026

Marker-Agnostic Tumor Anchoring Chimeras Enable pH-Gated Immune Engagement.

Marker-Agnostic Tumor Anchoring Chimeras Enable pH-Gated Immune Engagement.

Journal: Angewandte Chemie (International ed. in English)
Published: November 21, 2025

Structural and mechanistic insights into the constitutive Themis-Grb2 complex in T cell signalling.

Structural and mechanistic insights into the constitutive Themis-Grb2 complex in T cell signalling.

Journal: Nature communications
Published: April 18, 2025

Development of anti-murine IL-18 binding protein antibodies to stimulate IL-18 bioactivity.

Development of anti-murine IL-18 binding protein antibodies to stimulate IL-18 bioactivity.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: February 28, 2025

In silico design of stable single-domain antibodies with high affinity.

In silico design of stable single-domain antibodies with high affinity.

Journal: Structure (London, England : 1993)
Published: February 25, 2025

Reanalysis of cryo-EM data reveals ALK-cytokine assemblies with both 2:1 and 2:2 stoichiometries.

Reanalysis of cryo-EM data reveals ALK-cytokine assemblies with both 2:1 and 2:2 stoichiometries.

Journal: PLoS biology
Published: January 11, 2025

Improved protein binder design using β-pairing targeted RFdiffusion.

Improved protein binder design using β-pairing targeted RFdiffusion.

Journal: Nature communications
Published: December 20, 2024

Antibody-mediated TGF-β1 activation for the treatment of diseases caused by deleterious T cell activity.

Antibody-mediated TGF-β1 activation for the treatment of diseases caused by deleterious T cell activity.

Journal: Cell reports
Published: December 20, 2024

Small-angle X-ray scattering of engineered antigen-binding fragments: the case of glycosylated Fab from the Mannitou IgM antibody.

Small-angle X-ray scattering of engineered antigen-binding fragments: the case of glycosylated Fab from the Mannitou IgM antibody.

Journal: Acta crystallographica. Section F, Structural biology communications
Published: October 03, 2024

Single-domain antibodies directed against hemagglutinin and neuraminidase protect against influenza B viruses.

Single-domain antibodies directed against hemagglutinin and neuraminidase protect against influenza B viruses.

Journal: Nature communications
Published: July 03, 2024

The pros and confs of IL-18 activation.

The pros and confs of IL-18 activation.

Journal: Immunity
Published: June 05, 2024

The crystal structure of Nictaba reveals its carbohydrate-binding properties and a new lectin dimerization mode.

The crystal structure of Nictaba reveals its carbohydrate-binding properties and a new lectin dimerization mode.

Journal: Glycobiology
Published: May 06, 2024
Showing 1-12 of 98

Last Updated: 09/26/2026